Patents by Inventor Daren Anness

Daren Anness has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for relieving sinus congestion
    Patent number: 10517840
    Abstract: A method for temporarily relieving sinus congestion and pressure comprising administering to a human a dose of a multi-particle pulsatile oral dosage form with an immediate release form and a plurality of delayed release particles. The immediate release form contains about 10 mg phenylephrine hydrochloride. The delayed release form contains a core with coatings including a phenylephrine coating containing about 10 mg phenylephrine hydrochloride and a pH sensitive coating.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: December 31, 2019
    Assignee: The Procter & Gamble Company
    Inventors: Richard John Dansereau, Daren Anness, Guhan Balan, David Ramsey
  • Method For Relieving Sinus Congestion
    Publication number: 20190201355
    Abstract: A method for temporarily relieving sinus congestion and pressure comprising administering to a human a dose of a multi-particle pulsatile oral dosage form with an immediate release form and a plurality of delayed release particles. The immediate release form contains about 10 mg phenylephrine hydrochloride. The delayed release form contains a core with coatings including a phenylephrine coating containing about 10 mg phenylephrine hydrochloride and a pH sensitive coating.
    Type: Application
    Filed: March 7, 2019
    Publication date: July 4, 2019
    Inventors: Richard John Dansereau, Daren Anness, Guhan Balan, David Ramsey
  • Method for relieving sinus congestion
    Patent number: 10278930
    Abstract: A method for temporarily relieving sinus congestion and pressure comprising administering to a human a dose of a multi-particle pulsatile oral dosage form with an immediate release form and a plurality of delayed release particles. The immediate release form contains about 10 mg phenylephrine hydrochloride. The delayed release form contains a core with coatings including a phenylephrine coating containing about 10 mg phenylephrine hydrochloride and a pH sensitive coating.
    Type: Grant
    Filed: March 16, 2017
    Date of Patent: May 7, 2019
    Assignee: The Procter & Gamble Company
    Inventors: Richard John Dansereau, Daren Anness, Guhan Balan, David Ramsey
  • Method For Relieving Sinus Congestion
    Publication number: 20180263932
    Abstract: A method for temporarily relieving sinus congestion and pressure comprising administering to a human a dose of a multi-particle pulsatile oral dosage form with an immediate release form and a plurality of delayed release particles. The immediate release form contains about 10 mg phenylephrine hydrochloride. The delayed release form contains a core with coatings including a phenylephrine coating containing about 10 mg phenylephrine hydrochloride and a pH sensitive coating.
    Type: Application
    Filed: March 16, 2017
    Publication date: September 20, 2018
    Inventors: Richard John Dansereau, Daren Anness, Guhan Balan, David Ramsey